Samsung's Galaxy Watch3 and Watch Active2 both have hardware support for ECG monitoring, but it is taking a long time to show up for everyone, since the feature has to be approved by each country's health agencies. It was exclusive to South Korea until September of last year, when it was enabled for use in the United States, and now it's coming to 32 more countries.
Fitbit makes some of the most useful fitness-focused wearables these days. The company unveiled its new Sense smartwatch in August with the world's first electrodermal activity (EDA) sensor for detecting stress levels, and compatibility with a new ECG app that could even help users avoid strokes by alerting them to irregular heart rhythms. At least, it would, but at the time Fitbit was still waiting on FDA approval for that functionality. Now the feature is becoming available as the new ECG app rolls out to users.
The Galaxy Watch Active2 included hardware support for electrocardiogram (ECG) monitoring when it was released late last year, as did this year's Galaxy Watch3. The feature couldn't be enabled in the United States until it received FDA approval, leading to one of the watches' main selling points not (officially) working in America. At long last, Samsung has received the FDA's blessing, and ECG support is rolling out to both models. These features will also be coming to Galaxy Watches in the UK from February 22.
Samsung just unveiled the Galaxy Watch3 a couple days ago after plenty of leaksand speculation, but we're not done with the Watch3 news just yet. The Samsung Health app is currently being updated to support VO2max monitoring, and the FDA has approved its electrocardiogram (ECG) functionality for the US.
Withings, the French fitness company that was acquired by Nokia in 2016 and then sold back to Withings co-founder Éric Carreel the following year, has launched three new products at CES: the Move ECG, a fitness watch with an built-in ECG, the Withings Move, a basic analog fitness watch, and the BPM Core, a standalone health monitor.